Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.64 CAD | -0.61% | -3.53% | -51.04% |
Sales 2024 * | - | Sales 2025 * | 1.04M 761K | Capitalization | 25.78M 18.82M |
---|---|---|---|---|---|
Net income 2024 * | -74M -54.03M | Net income 2025 * | -54M -39.43M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 24.7 x |
P/E ratio 2024 * |
-0.24
x | P/E ratio 2025 * |
-0.34
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 80.93% |
Latest transcript on Aptose Biosciences Inc.
1 day | -0.61% | ||
1 week | -3.53% | ||
Current month | -2.96% | ||
1 month | -17.59% | ||
3 months | -38.58% | ||
6 months | -60.67% | ||
Current year | -51.04% |
Managers | Title | Age | Since |
---|---|---|---|
William Rice
CEO | Chief Executive Officer | 65 | 13-10-27 |
C. Payne
DFI | Director of Finance/CFO | 61 | 22-06-26 |
Chief Tech/Sci/R&D Officer | - | 19-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Denis Burger
BRD | Director/Board Member | 80 | 07-09-18 |
Bernd Seizinger
BRD | Director/Board Member | 67 | 22-09-12 |
Mark Vincent
BRD | Director/Board Member | 71 | 07-09-18 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 1.64 | -0.61% | 4,133 |
24-05-02 | 1.65 | -0.60% | 3,109 |
24-05-01 | 1.66 | -1.78% | 15,277 |
24-04-30 | 1.69 | +2.42% | 4,218 |
24-04-29 | 1.65 | -2.94% | 13,125 |
Delayed Quote Toronto S.E., May 03, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-51.04% | 18.84M | |
+25.69% | 47.86B | |
+46.90% | 41.42B | |
-3.46% | 40.66B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- APS Stock